All Posts

delveinsights-oncology-based-reports
Assessing the Opportunities and Challenges in the Oncology Segment

Oncology is the study of cancer and encompasses the diagnosis and treatment of cancer. The treatment of cancer requires a multidisciplinary approach which includes medications, surgical, and radiation. The type of approach adopted depends upon the stages, age, and the patient’s preference. Cancer encompasses a g...

Find More

iron-deficiency-anemia-market-size-share-trends-companies-cagr-growth-therapy-treatment-therapeutics-pipeline
Iron Deficiency Anemia Market Growth Anticipated to Fuel at a CAGR of 3.7% by 2030

Anemia is a serious cause of global health loss with over 80% of the total cases diagnosed in developing countries, according to several studies. Anemia is characterized by reduced quality of red blood cells, diminished hemoglobin levels and even altered morphology of red blood cells. The symptoms of the condition ...

Find More

Intratumoral Cancer Therapy Market
Intratumoral Cancer Therapy: A Potential Weapon To Fight the Battle Against Cancer

Cancer is a leading cause of global death, accounting for nearly 10 million deaths in 2020.  However, over the past years, the treatment paradigm of Cancer has transformed with several therapies such as chemotherapies, radiation therapies and immunotherapies available to treat cancer. Even then, there exists a...

Find More

pharma-news-updates-for-roche-mayo-clinic-owlstone-transmedics-google
Roche inks $3B deal; Owlstone raises $58M; FDA approves OCS heart system; Google, Mayo Clinic build brain-mapping AI algorithm

Roche’s Genentech taps Adaptimmune for T-Cell Therapy Collaboration for USD 3 Billion A collaboration valued more than USD 3 billion, Genentech, a member of the Roche Group, declared it will collaborate with Adaptimmune for developing and commercializing allogeneic T-cell therapies to treat multiple cancer indic...

Find More

systemic-lupus-erythematosus-market-trends-growth-size-share-cagr-therapies-therapy-drugs-therapeutics-treatments
Systemic Lupus Erythematosus Treatment Market: How the Leading Companies are Countering the Rising Prevalence?

Systemic Lupus Erythematosus is a chronic inflammatory disease that affects connective tissues such as cartilage and blood vessel lining, which provide strength and flexibility to body structures. Systemic Lupus Erythematosus affects multiple organs and structures, including the skin, joints, kidneys, lungs, centra...

Find More

business-consultant
Business Consultants: An Intense Drive to Work Excellence

Consultancy comes from the Latin consultare, which means "to discuss." Usually, a professional providing expert advice in a specific area can be called a consultant, a group of individuals - consultancy. Business Consultancy requires dealing with a broad range of activities, and every firm or individual involved...

Find More

pharma-consultant
Reliable Experts in Pharmacology Market: Pharma Consultants

In the new fast-paced world, with unlimited access to information and technology, it gets overwhelming for various companies, be it an established goliath or a new start-up, to take important decisions. It often leads to confusion and dilemmas causing delays in operations, financial losses, fiscal deficits, and oth...

Find More

recent-pharma-news-and-updates-for-Pfizer-Forte-Biosciences- Bone-Therapeutics-Versanis-Bio-AC-Immune
Pfizer’s RSV Vaccine; Forte Biosciences’ Atopic Dermatitis Asset; Bone Therapeutics’ Osteoarthritis Programme; JandJ’s HIV Vaccine Trial; Versanis Bio $70 M Series A Financing; AC Immune’s Alzheimer’s Antibody Drug

Pfizer’s RSV Vaccine enters in the late-stage of clinical trials  As the battle to get an effective Respiratory Syncytial Virus (RSV) vaccine on the market heats up, Pfizer is launching a critical late-stage study of its experimental vaccine against a severe version of a cold virus that may cause pneumonia ...

Find More

phenylketonuria-market
Which Pipeline Therapy is Expected to Capture the Eyeballs in the Phenylketonuria Market?

Phenylketonuria is an inherited disorder characterized by the absence or deficiency of an enzyme called phenylalanine hydroxylase (PAH), responsible for processing the amino acid phenylalanine. The condition affects one in 13,500 to 19,000 newborns in the United States, says NORD. DelveInsight’s Phenylketonuria epi...

Find More

charcot-marie-tooth-disease-market-cagr-trends-growth-size-share-forecast-therapies-therapy-therapeutics-treatment-drugs
Charcot-Marie-Tooth Disease Market Size Expects Growth Owing to Increasing Prevalence, Influx of Pharma Companies and Novel Therapies

Charcot-Marie-Tooth (CMT) disease is a rare, chronic and sensory neuropathy that causes weakness of the limbs and progresses gradually over time. It can lead to atrophy, sensory loss and complete limb dysfunction. However, rare, the condition is the most common inherited disorder that damages peripheral nerves with...

Find More